Printer Friendly 14,694,643 articles and books

Periodicals Literature Keyword Title Author Topic

Member login User name    Password    Remember me Join us Forgot password?

Submit articles free

Browse Infection topic

Drug therapy subtopic

Articles 1-56 out of 56 article(s) Title Author Type Date Words Polymer Therapeutic Protects Gut From Radiation Damage, Infection After Cancer Treatment. Dec 3, 2009 880 Anacor Initiates Phase I Clinical Development for AN3365 - A Novel Antibiotic for the Treatment of Gram-Negative Infections. Nov 17, 2009 588 PPD and Janssen Pharmaceutica Collaborate to Develop Compounds for Treatment of Irritable Bowel Syndrome and Bacterial Infections. Clinical report Nov 16, 2009 685 Idera Pharmaceuticals Presents Preclinical Data on IMO-2125, its Lead Drug Candidate for Chronic Hepatitis C Virus Infection, at Liver Meeting 2009. Nov 3, 2009 871 Easier treatment for oral yeast infection in people living with HIV. Bateman, Chris Report Oct 1, 2009 76 NIH Issues $2.87 Million Grant for Development of Ceragenin[TM] Based Drug to Treat Clostridium difficile and Shigella Gastrointestinal Infections. Sep 9, 2009 1121 Breast cancer drug effective against life-threatening fungal infections too. Jul 21, 2009 423 Popular cancer drug rituximab may lead to oft-fatal viral brain infection. May 19, 2009 417 FDA Advisory Announces Psoriasis Drug Raptiva Increases Rare, Fatal Brain Infection Risk. Mar 12, 2009 460 Psoriasis drug may be linked to fatal infection. Feb 22, 2009 252 Phase 1 Trial Begins for Investigational New Drug for MDR Gram-negative Infections. Feb 17, 2009 764 Infection is one of the commonest causes of death in burn patients, particularly those with extensive damage. Rode, H.; Vale, I.Do; Millar, A.J.W. Report Jan 1, 2009 2902 United States: Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections. Nov 25, 2008 123 Antimicrobial drug use and resistance in Europe. van de Sande-Bruinsma, Nienke; Grundmann, Hajo; Verloo, Didier; Tiemersma, Edine; Monen, Jos; Goosse Clinical report Nov 1, 2008 6303 Infection risk halts testing of drug for lupus; ZymoGenetics stock dives as partner stops midstage trial; Drug tested on other ills. Oct 28, 2008 336 FDA Approves Energex Systems, Inc. Non-Drug Therapy For HIV Research. Jul 14, 2008 652 Gilead Announces 72-Week Data From Two Pivotal Phase III Studies Evaluating Viread(R) for the Treatment of Chronic Hepatitis B. Apr 24, 2008 2878 United kingdom : [pounds sterling]4 million(USD 8 mn) from Wellcome Trust for sepsis drugs development. Mar 20, 2008 430 Amgen and Wyeth Announce Updates to U.S. Prescribing Information for Enbrel(R). Mar 17, 2008 2649 Alnylam to Webcast Conference Call to Discuss Phase II GEMINI Data for ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection. Feb 25, 2008 430 Streptomyces in Nature and Medicine is an Account of 50 Years of Genetic Studies of the Soil Inhabiting Microbes That Produce Most of the Antibiotics Used to Treat Infections. Feb 5, 2008 403 Drug doesn't cut HIV risk. Feb 5, 2008 722 NEW DRUG FIGHTS BACTERIAL INFECTIONS IN NOVEL WAY. Feb 1, 2008 1062 Alnylam Reports Positive Phase II Data for ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection. Jan 23, 2008 1089 Alnylam Reports Continued Progress in Clinical Development of ALN-RSV01 for the Treatment of Respiratory Syncytial Virus (RSV) Infection. Clinical report Dec 13, 2007 1343 Data from STEP Study Presented at Open Scientific Session Confirm Merck's Investigational HIV Vaccine was not Effective. Nov 7, 2007 3273 Gilead Announces 48-Week Data from Two Pivotal Phase III Studies Evaluating Viread(R) For the Treatment of Chronic Hepatitis B. Nov 2, 2007 2612 Impact of resistant pathogens on the treatment of otitis. Coates, Harvey Nov 1, 2007 2807 UPDATE: FDA Approves ISENTRESS(TM) (raltegravir) Tablets, First-in-Class Oral HIV-1 Integrase Inhibitor. Oct 15, 2007 9780 UPDATE: FDA Approves ISENTRESS(TM) (raltegravir) Tablets, First-in-Class Oral HIV-1 Integrase Inhibitor. Oct 12, 2007 9768 Gain an Insight into the Pipeline Status of Bacterial Infections Drugs by Company and by Stage as Well as a Summary of the Latest News and Developments in This Area. Aug 23, 2007 351 Report Provides Insight into the Pipeline Status of Herpes Simplex Virus Infection Drugs by Company and by Stage. Jul 25, 2007 382 ViroPharma granted fast track status by FDA for new hepatitis C virus infection treatment. Jul 1, 2007 185 Alnylam Initiates Phase II Clinical Trial to Evaluate Safety and Anti-viral Efficacy of ALN-RSV01 in the Treatment of Respiratory Syncytial Virus (RSV) Infection. Jun 26, 2007 1302 KaloBios Initiates a U.S. Phase 1 Study of Its Second Drug Candidate, KB001. Jun 11, 2007 384 REPEAT/FDA Approves New Indication for INVANZ(R) (ertapenem) for the Prevention of Surgical Site Infections (SSI) following Elective Colorectal Surgery in Adults. Dec 21, 2006 12745 FDA Approves New Indication for INVANZ(R) (ertapenem) for the Prevention of Surgical Site Infections (SSI) following Elective Colorectal Surgery in Adults. Dec 20, 2006 12745 Alnylam Initiates Clinical Program to Evaluate Anti-Viral Activity for ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection. Nov 28, 2006 1206 Drug abusers prone to bacterial infections. Mar 1, 2006 190 Alnylam Initiates Second Phase I Clinical Study of ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection; Both U.S. and European Trials Now Underway. Dec 19, 2005 1019 Alnylam Initiates Phase I Clinical Study of ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection. Dec 7, 2005 1103 Studies Continue to Highlight Hemispherx's Ampligen(R) as Broadly Effective Adjuvant to Avian Influenza Treatments; Ampligen(R) Demonstrates Strong Therapeutic Synergy with Relenza(R). Nov 3, 2005 763 Alnylam Submits IND Application for ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection; Represents First RNAi Therapeutic for Viral Infectious Diseases and Alnylam's Lead Clinical-Stage Program. Nov 1, 2005 1028 AETHLON MEDICAL LAUNCHES HEPATITIS-C CLINICAL TRIAL. Nov 1, 2005 539 Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: guidelines on care, treatment and support. Nov 1, 2005 82 Antigenics Initiates Phase 1 Clinical Trial of AG-707 Therapeutic Vaccine for Genital Herpes. Oct 18, 2005 731 HIV treatment in resource-limited settings: call for information. James, John S. Sep 30, 2005 517 Pharmacology Watch: Antibiotic Treatment of Acute Lower Respiratory Infection. Aug 1, 2005 1232 Pharmacology Watch: Antibiotic Treatment of Acute Lower Respiratory Infection. Clinical report Aug 1, 2005 1228 According to the Mayo Clinic, there have been reports that patients taking Humira[R] and Remicade[R], two rheumatoid arthritis medications, are at a higher risk for infections. Jun 22, 2005 33 Antimicrobial activity of isoprenoid-substituted xanthones from Cudrania cochinchinensis against vancomycin-resistant enterococci. Fukai, T.; Oku, Y.; Hou, A.-J.; Yonekawa, M.; Terada, S. Jun 1, 2005 2260 Guidelines for nonoccupational HIV prophylaxis. Finn, Robert Jun 1, 2005 642 Vaccine-Preventable Hepatitis (VPH) and high-risk patients with HIV. Advertisement Jun 1, 2005 1171 Are pediatricians adhering to principles of judicious antibiotic use for upper respiratory tract infections? Sheridan, Michael J. Oct 1, 2002 2688 Vancomycin-Resistant Organisms on a Burn Unit. NEWTON, TERRY Aug 1, 2001 1748 Prevpac-TAP. Jul 1, 1999 815

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles